TY - JOUR
T1 - First Total Synthesis and Structure-Activity Relationship of Iheyamide A, an Antitrypanosomal Linear Peptide Isolated from a Dapissp. Marine Cyanobacterium
AU - Iwasaki, Arihiro
AU - Teranuma, Kazuya
AU - Kurisawa, Naoaki
AU - Rahmawati, Yulia
AU - Jeelani, Ghulam
AU - Nozaki, Tomoyoshi
AU - Gerwick, William H.
AU - Suenaga, Kiyotake
N1 - Funding Information:
This work was supported by JSPS KAKENHI (Grant Numbers 18K14346 and 20H02870). W.H.G. acknowledges support from NIH GM107550.
Publisher Copyright:
© 2021 American Chemical Society and American Society of Pharmacognosy
PY - 2021/9/24
Y1 - 2021/9/24
N2 - Iheyamide A ( 1 ) is an antitrypanosomal linear peptide isolated from aDapissp. marine cyanobacterium by our group in 2020, and based on structure-activity relationships of its natural analogues, the C-terminal pyrrolinone moiety has been identified as the phamacophore for its antiparasitic activity. Further, we isolated this pyrrolinone moiety by itself as a new natural product from the marine cyanobacterium and named it iheyanone ( 2 ). As expected, iheyanone ( 2 ) showed antitrypanosomal activity, but its potency was weaker than iheyamide A ( 1 ). To clarify more detailed structure-activity relationships, we completed a total synthesis of iheyamide A ( 1 ) along with iheyanone ( 2 ) and evaluated the antitrypanosomal activities of several synthetic intermediates. As a result, we found that the longer the peptide chain, the stronger the antitrypanosomal activity. As iheyamide A ( 1 ) showed selective toxicity againstTrypanosoma brucei rhodesiense, these findings can provide design guidelines for antitrypanosomal drugs.
AB - Iheyamide A ( 1 ) is an antitrypanosomal linear peptide isolated from aDapissp. marine cyanobacterium by our group in 2020, and based on structure-activity relationships of its natural analogues, the C-terminal pyrrolinone moiety has been identified as the phamacophore for its antiparasitic activity. Further, we isolated this pyrrolinone moiety by itself as a new natural product from the marine cyanobacterium and named it iheyanone ( 2 ). As expected, iheyanone ( 2 ) showed antitrypanosomal activity, but its potency was weaker than iheyamide A ( 1 ). To clarify more detailed structure-activity relationships, we completed a total synthesis of iheyamide A ( 1 ) along with iheyanone ( 2 ) and evaluated the antitrypanosomal activities of several synthetic intermediates. As a result, we found that the longer the peptide chain, the stronger the antitrypanosomal activity. As iheyamide A ( 1 ) showed selective toxicity againstTrypanosoma brucei rhodesiense, these findings can provide design guidelines for antitrypanosomal drugs.
UR - http://www.scopus.com/inward/record.url?scp=85115649755&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85115649755&partnerID=8YFLogxK
U2 - 10.1021/acs.jnatprod.1c00792
DO - 10.1021/acs.jnatprod.1c00792
M3 - Review article
C2 - 34488344
AN - SCOPUS:85115649755
SN - 0163-3864
VL - 84
SP - 2587
EP - 2593
JO - Journal of Natural Products
JF - Journal of Natural Products
IS - 9
ER -